(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -1,361.86%-13.14M | 3,560.76%28.92M | -90.38%2.39M | 1.31M | -752K | 1.04M | 790K | 78.45%24.85M | 42.20%13.92M | -45.92%9.79M |
Net profit before non-cash adjustment | -175.37%-6.42M | 245.25%12.26M | 60.70%37.6M | --14.15M | --11.38M | --8.52M | --3.55M | 21.70%23.4M | 15.04%19.23M | 18.42%16.71M |
Total adjustment of non-cash items | 1,688.05%12.27M | -116.50%-346K | 48.18%8.05M | --3.84M | --1.43M | --686K | --2.1M | 78.42%5.43M | -1.04%3.05M | 15.81%3.08M |
-Depreciation and amortization | 36.36%645K | 22.13%585K | 12.79%1.94M | --509.07K | --481K | --473K | --479K | 24.05%1.72M | 11.04%1.39M | 28.34%1.25M |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | 19.36%157.88K | ---- | ---- | ---- | ---- | 180.17%132.28K | -121.68%-165K | 378.62%761K |
-Disposal profit | -1,300.00%-126K | --66K | -144.13%-83.32K | ---74.32K | --0 | ---9K | --0 | 256.02%188.79K | -37.50%-121K | -104.65%-88K |
-Net exchange gains and losses | 160.85%401K | -384.82%-1.69M | 807.63%2.43M | --2.25M | --252K | ---659K | --593K | 369.96%267.88K | -47.71%57K | -66.67%109K |
-Other non-cash items | -395.35%-2.6M | -32.49%692K | 15.38%3.6M | --1M | --693K | --881K | --1.03M | 65.54%3.12M | 80.48%1.89M | -15.73%1.05M |
Changes in working capital | -132.65%-18.98M | 450.06%17.01M | -985.25%-43.26M | ---16.69M | ---13.56M | ---8.16M | ---4.86M | 52.25%-3.99M | 16.51%-8.35M | -849.55%-10M |
-Change in receivables | -277.61%-18.08M | 1,051.86%26.89M | -556.75%-48.73M | ---29.58M | ---11.54M | ---4.79M | ---2.83M | 198.13%10.67M | -265.53%-10.87M | -6.02%-2.97M |
-Change in inventory | 75.53%-1.83M | -26.77%-6.56M | -23.24%-21.88M | --8.69M | ---17.91M | ---7.49M | ---5.17M | -516.71%-17.76M | 7.81%-2.88M | -745.25%-3.12M |
-Change in payables | -77.54%924K | -205.92%-3.33M | 781.86%27.35M | --4.21M | --15.89M | --4.11M | --3.14M | -42.60%3.1M | 238.44%5.4M | -206.76%-3.9M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 0 | -69K | ||||||||
Interest received (cash flow from operating activities) | 1,550.00%297K | 751.61%264K | 57.25%284.94K | 142.94K | 93K | 18K | 31K | -34.11%181.2K | -58.14%275K | 60.24%657K |
Tax refund paid | -335.56%-4.24M | -28.42%-1.37M | -48.87%-8.18M | -2.69M | -3.44M | -973K | -1.07M | -14.99%-5.49M | 10.48%-4.78M | -2,144.06%-5.34M |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | -19,956.98%-17.08M | 11,453.06%27.82M | -128.16%-5.5M | ---1.24M | ---4.1M | --86K | ---245K | 107.33%19.53M | 86.80%9.42M | -73.13%5.04M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -517.19%-1.36M | -68.96%-1.74M | 72.92%-2.6M | ---817.93K | ---534K | ---221K | ---1.03M | -11.59%-9.61M | 41.59%-8.62M | -3,721.76%-14.75M |
Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2 | ---- | ---- |
Net investment product transactions | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -80.60%200K | 226.50%1.03M | -3,360.00%-815K |
Net changes in other investments | 1,692.37%4.17M | 173.10%2.27M | ---- | ---- | ---501K | ---262K | ---3.11M | ---- | -635.45%-5.39M | 200.00%1.01M |
Investing cash flow | 681.37%2.81M | 112.84%532K | 72.34%-2.6M | --3.06M | ---1.04M | ---483K | ---4.14M | 27.45%-9.41M | 10.87%-12.98M | -964.33%-14.56M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 147.68%3.31M | -89.97%498K | -91.68%201.9K | --878.9K | --1.31M | ---6.95M | --4.96M | -79.49%2.43M | -55.50%11.83M | 1,046.21%26.58M |
Net common stock issuance | ---- | ---- | --33.02M | ---1.38M | --1M | ---- | ---- | --0 | ---- | --0 |
Increase or decrease of lease financing | 748.80%811K | 6.92%-148K | 15.09%-520.99K | ---111.99K | ---125K | ---125K | ---159K | 2.14%-613.56K | 14.23%-627K | -22.24%-731K |
Issuance fees | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | --0 | -1,042.86%-8M | 88.14%-700K | --0 | --0 | --0 | ---700K | 7.64%-5.9M | 52.33%-6.39M | -528.81%-13.4M |
Interest paid (cash flow from financing activities) | -9.57%-985K | 22.97%-815K | -9.04%-3.65M | ---903.25K | ---785K | ---899K | ---1.06M | -60.34%-3.34M | -118.10%-2.09M | 42.06%-956K |
Net other fund-raising expenses | ---- | ---- | 9.44%-1.27M | ---- | ---- | ---- | ---- | -137.46%-1.4M | 200.89%3.73M | -9,342.50%-3.7M |
Financing cash flow | -87.47%3.14M | -377.81%-8.47M | 406.87%27.09M | ---1.4M | --398K | --25.05M | --3.05M | -236.70%-8.83M | -17.15%6.46M | 228.63%7.8M |
Net cash flow | ||||||||||
Beginning cash position | 260.80%53.68M | 106.94%34.77M | 5.42%16.8M | --34.78M | --40.03M | --14.88M | --16.8M | 22.43%15.94M | -12.54%13.02M | 310.88%14.88M |
Current changes in cash | -145.15%-11.13M | 1,583.73%19.88M | 1,369.98%18.99M | --413.82K | ---4.74M | --24.65M | ---1.34M | -55.51%1.29M | 268.68%2.9M | -115.17%-1.72M |
Effect of exchange rate changes | 20.72%606K | -65.92%-964K | -138.51%-1.02M | ---425.03K | ---516K | --502K | ---581K | -2,475.88%-427.66K | 112.41%18K | -66.67%-145K |
End cash Position | 7.81%43.16M | 260.80%53.68M | 106.94%34.77M | --34.77M | --34.78M | --40.03M | --14.88M | 5.41%16.8M | 22.44%15.94M | -12.54%13.02M |
Free cash flow | -10,430.06%-18.22M | 2,125.78%25.85M | -182.52%-8.14M | ---2.06M | ---4.64M | ---173K | ---1.28M | 1,366.28%9.87M | 106.79%673K | -154.56%-9.92M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data